Europäische Marktprognose für Osteoarthritis-Therapien bis 2030 – Regionale Analyse – nach Therapietyp (transkutane elektrische Nervenstimulation (TENS), Ergotherapie, Physiotherapie, plättchenreiche Plasmatherapie und Stroma-Gefäßfraktion, Prolotherapie und andere), Krankheitsindikation (Kniearthrose, Wirbelsäulenarthrose, Fuß- und Sprunggelenkarthrose, Schulterarthrose, Handarthrose und andere) und Endverbraucher (Krankenhäuser und Kliniken, Fachkliniken, ambulante chirurgische Zentren, häusliche Pflege und andere)
Verfügbarkeit regenerativer Medizin treibt europäischen Markt für Osteoarthritis-Therapien an
Regenerative Medizin ist eine neue und potenziell transformative Alternative zu herkömmlichen Therapieoptionen zur Behandlung von OA. Regenerative Medizin nutzt biomedizinische Technik, Biomaterialien und Zelltherapien, die auf das Immunsystem des Körpers abzielen, um OA zu behandeln. Darüber hinaus haben klinische Forscher Methoden entwickelt, um den Gelenkknorpel von Patienten mithilfe von (autologen) Zellen der Patienten zu reparieren. Darüber hinaus verwenden regenerative Therapieoptionen die „Matrix-Induced Autologous Chondrocyte Implantation (MACI)“. MACI kann kleine Knorpelbereiche reparieren und so letztendlich OA verhindern oder hinauszögern. Darüber hinaus entwickeln mehrere Hersteller Produkte, die sich auf regenerative Therapie konzentrieren. Die zunehmende Neigung zu nicht-chirurgischen Ansätzen wie PRP-Therapie, Stammzellentherapie, Hyaluronsäure-Injektionen und Prolotherapie würde die Einführung der regenerativen Medizin vorantreiben. Patienten, die an OA leiden, können mit nicht-pharmakologischen Therapien behandelt werden. Regenerative Therapieoptionen können die Gelenkfunktionen verbessern, indem sie letztlich Schmerzen lindern und die allgemeine Lebensqualität von Personen, die an OA leiden, verbessern. Daher wird erwartet, dass die zunehmende Einführung der regenerativen Medizin im Prognosezeitraum neue Geschäftsmöglichkeiten auf dem Markt für Osteoarthritis-Therapien eröffnen wird.
Überblick über den europäischen Markt für Osteoarthritis-Therapien
Der europäische Markt für Osteoarthritis-Therapien ist in Deutschland, Großbritannien, Frankreich, Italien, Spanien und das übrige Europa unterteilt. Schnelle Produktzulassungen in der Region für Medikamente zur Behandlung von Osteoarthritis und eine fortschrittliche Gesundheitsinfrastruktur sind die einflussreichsten Faktoren für das Marktwachstum. Laut dem Bericht des Journal of Health Monitoring ist Osteoarthritis die häufigste Gelenkerkrankung in Deutschland. Gelenkschmerzen und Funktionsverlust führen wahrscheinlich zu einem Verlust der Lebensqualität, da Osteoarthritis in den oberen Extremitäten (Finger, Hände und Schultern) verursacht wird. Daher wird mit der Alterung der deutschen Bevölkerung die Prävalenz von Arthrose weiter steigen, was zu einer hohen Belastung des Gesundheitssystems führt. Laut dem im Jahr 2020 veröffentlichten Bericht der Weltgesundheitsorganisation (WHO) machen Arthrose-Todesfälle in Deutschland 0,05 % aller Todesfälle aus. Darüber hinaus fördern neue Produkteinführungen das Marktwachstum. So gab Grünenthal im Mai 2023 bekannt, dass es die Zulassung für das experimentelle nicht-opioide Arzneimittel „Resiniferatoxin (RTX)“ erhalten hat, das sich derzeit in der klinischen Phase 3 der Entwicklung befindet und von der US-amerikanischen Food and Drug Administration (USFDA) als bahnbrechende Therapie zur Behandlung von Kniearthrose eingestuft wird. Resiniferatoxin kann eine sinnvolle nicht-opioide Behandlungsoption werden, die eine langanhaltende Schmerzlinderung und eine funktionelle Verbesserung des betroffenen Gelenks bietet.
Umsatz und Prognose des europäischen Marktes für Arthrosetherapie bis 2030 (Mio. USD)
Segmentierung des europäischen Marktes für Arthrosetherapie
Der europäische Markt für Arthrosetherapie ist nach Therapietyp, Krankheitsindikationen, Endverbraucher und Land kategorisiert.
Basierend auf der Therapieart ist der europäische Markt für Osteoarthritis-Therapien segmentiert in transkutane elektrische Nervenstimulation (TENS), Beschäftigungstherapie, Physiotherapie, plättchenreiche Plasmatherapie (PRP) und Stroma-Gefäßfraktion, Prolotherapie und andere. Das Segment Physiotherapie hatte 2022 den größten Marktanteil.
In Bezug auf Krankheitsindikationen ist der europäische Markt für Osteoarthritis-Therapien segmentiert in Kniearthrose, Wirbelsäulenarthrose, Fuß- und Sprunggelenkarthrose, Schulterarthrose, Handarthrose und andere. Das Segment Kniearthrose hatte 2022 den größten Anteil am europäischen Markt für Osteoarthritis-Therapien.
Basierend auf den Endnutzern ist der europäische Markt für Osteoarthritis-Therapien kategorisiert in Krankenhäuser und Kliniken, Fachkliniken, ambulante chirurgische Zentren, häusliche Pflege und andere. Das Segment Heimpflege hatte 2022 den größten Anteil am europäischen Markt für Arthrosetherapie.
Nach Ländern ist der europäische Markt für Arthrosetherapie in Großbritannien, Deutschland, Frankreich, Italien, Spanien und das übrige Europa unterteilt. Deutschland dominierte 2022 den europäischen Marktanteil für Arthrosetherapie.
Zimmer Biomet Holdings Inc, DePuy Synthes Inc, Bioventus Inc, Omron Healthcare Inc, Exactech Inc und Medi GmbH & Co KG sind einige der führenden Unternehmen auf dem europäischen Markt für Arthrosetherapie.
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Osteoarthritis Therapy Market Landscape
4.1 Pipeline Analysis
4.1.1 Clinical Trial Pipeline Analysis
5. Europe Osteoarthritis Therapy Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Prevalence of Osteoarthritis
5.1.2 Innovative Therapy Options Reducing Dependency on Medications
5.2 Market Restraints
5.2.1 Product Recall
5.3 Market Opportunities
5.3.1 Availability of Regenerative Medicine
5.4 Future Trends
5.4.1 More Effective Treatment Options
5.5 Impact of Drivers and Restraints:
6. Osteoarthritis Therapy Market - Europe Market Analysis
6.1 Overview
6.1.1 Osteoarthritis Therapy Market Revenue (US$ Million), 2020-2030
7. Europe Osteoarthritis Therapy Market Analysis - by Therapy Type
7.1 Overview
7.2 Transcutaneous Electrical Nerve Stimulation (TENS)
7.2.1 Overview
7.2.2 Transcutaneous Electrical Nerve Stimulation (TENS): Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Occupational Therapy
7.3.1 Overview
7.3.2 Occupational Therapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Physical Therapy
7.4.1 Overview
7.4.2 Physical Therapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Platelet-Rich Plasma Therapy and Stromal Vascular Fraction
7.5.1 Overview
7.5.2 Platelet-Rich Plasma Therapy and Stromal Vascular Fraction: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Prolotherapy
7.6.1 Overview
7.6.2 Prolotherapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
7.7 Others
7.7.1 Overview
7.7.2 Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8. Europe Osteoarthritis Therapy Market Analysis - by Disease Indication
8.1 Overview
8.2 Knee Osteoarthritis
8.2.1 Overview
8.2.2 Knee Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8.3 Spine Osteoarthritis
8.3.1 Overview
8.3.2 Spine Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Foot and Ankle Osteoarthritis
8.4.1 Overview
8.4.2 Foot and Ankle Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Shoulder Osteoarthritis
8.5.1 Overview
8.5.2 Shoulder Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8.6 Hand Osteoarthritis
8.6.1 Overview
8.6.2 Hand Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8.7 Others
8.7.1 Overview
8.7.2 Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
9. Europe Osteoarthritis Therapy Market Analysis - by End User
9.1 Overview
9.2 Hospitals and Clinics
9.2.1 Overview
9.2.2 Hospitals and Clinics: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
9.3 Specialty Clinics
9.3.1 Overview
9.3.2 Specialty Clinics: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Ambulatory Surgical Centers
9.4.1 Overview
9.4.2 Ambulatory Surgical Centers: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Homecare
9.5.1 Overview
9.5.2 Homecare: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10. Europe Osteoarthritis Therapy Market - Country Analysis
10.1 Europe Market Overview
10.1.1 Europe: Osteoarthritis Therapy Market - Revenue and Forecast Analysis - by Country
10.1.1.1 United Kingdom: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.1.1 Overview
10.1.1.1.2 United Kingdom: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.1.3 United Kingdom: Osteoarthritis Therapy Market Breakdown, by Therapy Type
10.1.1.1.4 United Kingdom: Osteoarthritis Therapy Market Breakdown, by Disease Indication
10.1.1.1.5 United Kingdom: Osteoarthritis Therapy Market Breakdown, by End User
10.1.1.2 Germany: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.1 Overview
10.1.1.2.2 Germany: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.3 Germany: Osteoarthritis Therapy Market Breakdown, by Therapy Type
10.1.1.2.4 Germany: Osteoarthritis Therapy Market Breakdown, by Disease Indication
10.1.1.2.5 Germany: Osteoarthritis Therapy Market Breakdown, by End User
10.1.1.3 France: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.1 Overview
10.1.1.3.2 France: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.3 France: Osteoarthritis Therapy Market Breakdown, by Therapy Type
10.1.1.3.4 France: Osteoarthritis Therapy Market Breakdown, by Disease Indication
10.1.1.3.5 France: Osteoarthritis Therapy Market Breakdown, by End User
10.1.1.4 Italy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.4.1 Overview
10.1.1.4.2 Italy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.4.3 Italy: Osteoarthritis Therapy Market Breakdown, by Therapy Type
10.1.1.4.4 Italy: Osteoarthritis Therapy Market Breakdown, by Disease Indication
10.1.1.4.5 Italy: Osteoarthritis Therapy Market Breakdown, by End User
10.1.1.5 Spain: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.5.1 Overview
10.1.1.5.2 Spain: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.5.3 Spain: Osteoarthritis Therapy Market Breakdown, by Therapy Type
10.1.1.5.4 Spain: Osteoarthritis Therapy Market Breakdown, by Disease Indication
10.1.1.5.5 Spain: Osteoarthritis Therapy Market Breakdown, by End User
10.1.1.6 Rest of Europe: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.6.1 Overview
10.1.1.6.2 Rest of Europe: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.6.3 Rest of Europe: Osteoarthritis Therapy Market Breakdown, by Therapy Type
10.1.1.6.4 Rest of Europe: Osteoarthritis Therapy Market Breakdown, by Disease Indication
10.1.1.6.5 Rest of Europe: Osteoarthritis Therapy Market Breakdown, by End User
11. Industry Landscape
11.1 Overview
11.2 Growth Strategies in the osteoarthritis therapy market
11.3 Organic Developments
11.3.1 Overview
11.1 Inorganic Developments
11.1.1 Overview
12. Company Profiles
12.1 Zimmer Biomet Holdings Inc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 DePuy Synthes Inc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Bioventus Inc
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Omron Healthcare Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Exactech Inc
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Medi GmbH & Co KG
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
13. Appendix
13.1 About the Insight Partners
List of Tables
Table 1. Osteoarthritis Therapy Market Segmentation
Table 2. Ongoing Clinical Trial of Osteoarthritis
Table 3. United Kingdom: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 4. United Kingdom: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 5. United Kingdom: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 6. Germany: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 7. Germany: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 8. Germany: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 9. France: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 10. France: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 11. France: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 12. Italy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 13. Italy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 14. Italy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 15. Spain: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 16. Spain: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 17. Spain: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 18. Rest of Europe: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 19. Rest of Europe: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 20. Rest of Europe: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 21. Organic Developments Done by Companies
Table 22. Inorganic Developments Done by Companies
List of Figures
Figure 1. Osteoarthritis Therapy Market Segmentation, by Country
Figure 2. Osteoarthritis Therapy Market - Key Market Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Osteoarthritis Therapy Market Revenue (US$ Million), 2020-2030
Figure 5. Osteoarthritis Therapy Market Share (%) - by Therapy Type (2022 and 2030)
Figure 6. Transcutaneous Electrical Nerve Stimulation (TENS): Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Occupational Therapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Physical Therapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Platelet-Rich Plasma Therapy and Stromal Vascular Fraction: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Prolotherapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Osteoarthritis Therapy Market Share (%) - by Disease Indication (2022 and 2030)
Figure 13. Knee Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Spine Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Foot and Ankle Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Shoulder Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Hand Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Osteoarthritis Therapy Market Share (%) - by End User (2022 and 2030)
Figure 20. Hospitals and Clinics: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Specialty Clinics: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Ambulatory Surgical Centers: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Homecare: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 24. Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. Europe: Osteoarthritis Therapy Market - Revenue by Key Countries Revenue 2022 (US$ Million)
Figure 26. Europe: Osteoarthritis Therapy Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 27. United Kingdom: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 28. Germany: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 29. France: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 30. Italy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 31. Spain: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 32. Rest of Europe: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 33. Growth Strategies in the Osteoarthritis Therapy market
1. Zimmer Biomet Holdings Inc
2. DePuy Synthes Inc
3. Bioventus Inc
4. Omron Healthcare Inc
5. Exactech Inc
6. Medi GmbH & Co KG
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe osteoarthritis therapy market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Europe osteoarthritis therapy market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the Europe osteoarthritis therapy market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.